4
Changes in Ownership
Inhibikase Therapeutics, Inc. Filed Acc 0000950170-25-007746
Options or other derivatives
- Chief Financial Officer acquired 95,834 shares (grant or award)
- Chief Financial Officer returned 95,834 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/ownership.xml…